Investors’ data

Latest news

December 10, 2008

Thallion Announces a Review of Strategic Alternatives

November 18, 2008

Thallion Initiates Enrollment in Phase II Metastatic Melanoma Trial

October 24, 2008

Thallion's TLN-4601 Inhibits Mutated K-RAS Signaling in Cancer Cells

Documentation

Stock Information

Thallion is listed on the Toronto Stock Exchange under the symbol "TLN".

Symbol TSX : TLN
Last trade 0.18
Open 0.18
Net change 0.00
High 0.18
Low 0.18
52 week range 0.06 - 0.79
Volume 29,557
As of 2009-01-06 14:44 EST
Note: Quotes are delayed.
For informational purposes only.